相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections
Marie Hocquart et al.
CLINICAL INFECTIOUS DISEASES (2018)
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France
Emilie Baro et al.
PLOS ONE (2017)
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
Colleen R. Kelly et al.
ANNALS OF INTERNAL MEDICINE (2016)
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection A Randomized Clinical Trial
Christine H. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia
Gregory Merlo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study
D. N. Shah et al.
JOURNAL OF HOSPITAL INFECTION (2016)
High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong
Sunny H. Wong et al.
JOURNAL OF INFECTION (2016)
Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection
Lauren Lapointe-Shaw et al.
PLOS ONE (2016)
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
Sinan Wang et al.
PLOS ONE (2016)
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
G. Cammarota et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Fecal Microbiota Transplantation for Clostridium difficile Infection A Systematic Review
Dimitri Drekonja et al.
ANNALS OF INTERNAL MEDICINE (2015)
Clostridium difficile Ribotype 027: Relationship to Age, Detectability of Toxins A or B in Stool With Rapid Testing, Severe Infection, and Mortality
Krishna Rao et al.
CLINICAL INFECTIOUS DISEASES (2015)
Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report
J. -C. Lagier et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent
Samuel L. Aitken et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Raghu U. Varier et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Evaluation of Portability and Cost of a Fluorescent PCR Ribotyping Protocol for Clostridium difficile Epidemiology
Jonathan N. V. Martinson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis
Gauree G. Konijeti et al.
CLINICAL INFECTIOUS DISEASES (2014)
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2014)
Clinical characteristics of relapses and re-infections in Clostridium difficile infection
J. Kim et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection
R.U. Varier et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Health Care-Associated Infections A Meta-analysis of Costs and Financial Impact on the US Health Care System
Eyal Zimlichman et al.
JAMA INTERNAL MEDICINE (2013)
The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital
Alan J. Forster et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
Patient Attitudes Toward the Use of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium difficile Infection
Jonathan S. Zipursky et al.
CLINICAL INFECTIOUS DISEASES (2012)
Association of Relapse of Clostridium difficile Disease with BI/NAP1/027
Jane W. Marsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Type-Specific Risk Factors and Outcome in an Outbreak With 2 Different Clostridium difficile Types Simultaneously in 1 Hospital
A. Goorhuis et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong
V. C. C. Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Economic healthcare costs of Clostridium difficile infection: a systematic review
S. S. Ghantoji et al.
JOURNAL OF HOSPITAL INFECTION (2010)
What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability?
Marco Barbieri et al.
VALUE IN HEALTH (2010)
Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities
J. H. S. You et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2009)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Cost effectiveness of adult intensive care in the UK
S. Ridley et al.
ANAESTHESIA (2007)
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
分享论文
